Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.
about
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expressionGene expression signature-based screening identifies new broadly effective influenza a antiviralsPedilanthus tithymaloides Inhibits HSV Infection by Modulating NF-κB SignalingAkt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro.Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)Host response to influenza virus: protection versus immunopathology.Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.Innate immune evasion strategies of influenza virusesReverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cellsPrtT-regulated proteins secreted by Aspergillus fumigatus activate MAPK signaling in exposed A549 lung cells leading to necrotic cell death.Early activation of MAP kinases by influenza A virus X-31 in murine macrophage cell linesNew treatments for influenzaSystematic approaches towards the development of host-directed antiviral therapeutics.CYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes.Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic studyModes of Antiviral Action of Chemical Portions and Constituents from Woad Root Extract against Influenza Virus A FM1.Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I.Characteristics of human infection with avian influenza viruses and development of new antiviral agents.Innate immune responses to influenza A H5N1: friend or foe?Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection.Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry.Influenza A Virus and Influenza B Virus Can Induce Apoptosis via Intrinsic or Extrinsic Pathways and Also via NF-κB in a Time and Dose Dependent Manner.Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response.Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release.The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.Inhibition of enveloped virus infection of cultured cells by valproic acid.Identification of Polo-like kinases as potential novel drug targets for influenza A virus.The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs.Anti-inflammatory effects of indirubin derivatives on influenza A virus-infected human pulmonary microvascular endothelial cells.Interfering With Lipid Raft Association: A Mechanism to Control Influenza Virus Infection By Sambucus Nigra.Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USA.Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling Pathways.The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus.Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug targetDeep sequencing of primary human lung epithelial cells challenged with H5N1 influenza virus reveals a proviral role for CEACAM1
P2860
Q21135459-1977B86B-CC9E-4423-8DA6-8CBE39CA211DQ28475681-6282342D-0068-44D1-BDEE-7E17152B132AQ28548460-45D198F6-C009-4995-AECF-775BE23777EDQ30361598-8868FA64-DA0D-49D2-8A57-378050B622D1Q30382531-6CD6E1BE-B3AE-4B9B-8C54-4B7D8D96C688Q30391010-B9526AE4-2D0B-4DDA-B462-0E7CBD3581CFQ30431968-18026B3A-93FB-4BB3-B7B6-9A39C7FDB68AQ33646273-FAE583B4-38AD-4136-819B-24B379370B42Q33745109-A4460682-D3AA-421A-B4ED-150CB672AD62Q33848942-63485626-F84B-4253-A11E-1188F7D46548Q34104767-1357AA0F-1CE9-452B-8447-3D4B8DC136FEQ34413797-70AC59D4-F8DA-4B3B-98AD-59CB03BAD173Q35091855-98D8B760-85D6-4361-B4A2-2F4179361374Q35412516-E940BEE8-A7E3-4445-83D2-C435DA33DBA9Q35494999-79987DC2-F6B5-49C7-B09C-DD5C2006F51BQ35715406-C5A674E4-9D07-4457-AE71-0858DAA4AEB9Q36137910-57688EE0-C858-49B6-BEE0-C21A02C6EE03Q36644085-A6E10AA6-4CB2-4DD4-805A-A24B915D2F6CQ37117819-00C914B6-2E82-44D2-88FB-8E4AF094325DQ37217863-DC7E4629-07FF-4297-AEDB-F11C7DA1168BQ37346635-1C291105-FBF0-4156-838D-BBC2B6774CAFQ38719035-21E67115-3718-4FDC-8CBB-896F427DFD71Q38819040-52467B1B-8B06-44B0-9343-3972798BA806Q39024479-91F6B918-AA1C-46D4-8F40-211D2105122AQ39113607-82A29339-6C01-45F7-A631-0C0F1834F3B5Q39327655-E256D4DD-A48F-499A-9A6B-41BE53440601Q39686446-1D3D239B-CC02-435A-921C-11E143A0A4E5Q39813573-BB52CB20-4B86-49D3-9BC1-2C181004067AQ40078929-6CE54000-D335-4B7B-88E5-AABD26EE304DQ40682223-AC4FB207-C5FF-48EB-9304-71D2A0C1B166Q40844952-4E436B49-8214-454D-8E45-7B3C188018B4Q45323853-AEEAA6C0-D5E5-4B64-98FE-33CA6F649E30Q46139825-8ACAB0BC-254F-4740-8A12-43EA532C61B4Q47221720-7A409066-6EB0-4A25-9FA7-5A1B763FBCB4Q55080745-70103E8D-D3DD-42B6-BBA7-067FE8B8A79EQ57093675-0592EB60-F8F4-4E7E-93B3-89D986BBE1D1Q57811563-8946B5BE-9F35-4DC9-B609-9AA34CD66BC1
P2860
Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting cell signalling path ...... nge in anti-influenza therapy.
@en
Targeting cell signalling path ...... nge in anti-influenza therapy.
@nl
type
label
Targeting cell signalling path ...... nge in anti-influenza therapy.
@en
Targeting cell signalling path ...... nge in anti-influenza therapy.
@nl
prefLabel
Targeting cell signalling path ...... nge in anti-influenza therapy.
@en
Targeting cell signalling path ...... nge in anti-influenza therapy.
@nl
P2093
P2860
P356
P1476
Targeting cell signalling path ...... nge in anti-influenza therapy.
@en
P2093
Barbara A Jacob
David M Guidot
Dean P Jones
Michael Koval
Pratibha C Joshi
Roy L Sutliff
P2860
P356
10.2217/14750708.6.1.1
P407
P577
2009-05-06T00:00:00Z